INVESTIGADORES
MOLEJON Maria Ines
artículos
MOLEJÓN, MI; WEIZ G; BRECCIA J; VACCARO, MI
Glycoconjugation: An approach to cancer therapeutics
Wrold Journal of Clinical Oncology; Año: 2020
MOLEJÓN, MI; WEIZ G; TELLECHEA JI; BRECCIA J; VACCARO, MI; VACCARO MI
Antitumoral effects of glycoconjugates on primary cultures of human pancreatic cancer cells obtained by echoendoscopy
Acta Gastroenterólogica Latinoamericana; Año: 2019
MOLEJON MI; SWAYDEN M; FANALE D; BINTZ J; GAYET O; SOUBEYRAN P; IOVANNA, JL
Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma
Oncotarget; Lugar: NY; Año: 2018
LONCLE C; BONJOCH L; FOLCH-PUY E; LOPEZ MILLAN MB; LAC S; MOLEJON MI; CHULUYAN E; CORDELIER P; DUBUS P; LOMBERK G; URRUTIA R; CLOSA D; IOVANNA JL
REG3b Plays a Key Role in IL17RA Protumoral Effect?Response
CANCER RESEARCH; Lugar: Philadelphia; Año: 2016
LONCLE C; MOLEJON MI; LAC S; TELLECHEA JI; LOMBERK G; GRAMATICA L; FERNANDEZ-ZAPICO, ME; DUSETTI N; URRUTIA R; IOVANNA JL
The Pancreatitis-Associated Protein VMP1, a Key Regulator of Inducible Autophagy, Promotes KrasG12D-Mediated Pancreatic Cancer Initiation
Cell Death and Disease; Año: 2016
MOLEJON MI; TELLECHEA JI; LONCLE C; GAYET O; GILABERT M; DUCONSEIL P; LOPEZ MILLAN MB; MOUTARDIER V; GASMI M; GARCIA S; TURRINI O; OUAISSI M; POIZAT F; DUSETTI N; IOVANNA JL
Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma
Oncotarget; Año: 2015
MOLEJON MI; IOVANNA, JL
IER3 in pancreatic carcinogenesis
Oncotarget; Año: 2015
LOPEZ MB; GARCIA MN; GRASSO D; BINTZ J; MOLEJON MI; VELEZ G; LOMBERK G; NEIRA J; URRUTIA R; IOVANNA JL
Functional Characterization of Nupr1L, a novelp53-Regulated Isoform of theHigh Mobility Group (HMG)-Related Protumoral Protein Nupr1
JOURNAL OF CELLULAR PHYSIOLOGY; Lugar: New York; Año: 2015
MOLEJÓN, MI; TELLECHEA JI; MOUTARDIER V; GASMI M; OUAISSI M; TURRINI O; DELPERO JR; DUSETTI N; IOVANNA JL
Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence.
Oncoscience; Año: 2015
LONCLE C; BONJOCH L; FOLCH-PUY E; LOPEZ MB; LAC S; MOLEJON MI; CHULUYAN E; CORDELIER P; DUBUS P; LOMBERK G; URRUTIA R; IOVANNA JL
IL-17 functions through the novel REG3β-JAK2-STAT3 inflammatory pathway to promote the transition from chronic pancreatitis to pancreatic cancer.
Cancer Research; Año: 2015
GRASSO D; BINTZ J; LOMBERK G; MOLEJON MI; LONCLE C; GARCIA MN; LOPEZ MB; URRUTIA R; IOVANNA JL
Pivotal Role of the Chromatin Protein Nupr1 in Kras-Induced Senescence and Transformation
Scientific Reports; Año: 2015
MOLEJON MI; ROPOLO A; VACCARO MI
VMP1 IS A NEW PLAYER IN THE REGULATION OF THE AUTOPHAGY-SPECIFIC PHOSPHATIDYLINOSITOL 3-KINASE COMPLEX ACTIVATION
AUTOPHAGY; Lugar: Austin, Texas; Año: 2013 p. 2 - 3
HAMIDI T; ALGÜL H; CANO CE; SANDI MJ; MOLEJON MI; RIEMANN M; CALVO EL; LOMBERK G; DAGORN JC; WEIH F; URRUTIA R; SCHMID RM; IOVANNA JL.
Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis.
JOURNAL OF CLINICAL INVESTIGATION; Lugar: Ann Arbor, Michigan; Año: 2012 p. 2092 - 2103
MOLEJON MI; ROPOLO A; LO RE A; BOGGIO V; VACCARO MI
The VMP1-Beclin 1 interaction regulates Autophagy induction
Scientific Reports; Año: 2012
LO RE AE; FERNÁNDEZ-BARRENA MG; ALMADA LL; MILLS LD; ELSAWA SF; LUND G; ROPOLO A; MOLEJON MI; VACCARO MI; FERNANDEZ-ZAPICO, ME
Novel AKT1-GLI3-VMP1 Pathway Mediates KRAS Oncogene-induced Autophagy in Cancer Cells
JOURNAL OF BIOLOGICAL CHEMISTRY; Lugar: Bethesda, Maryland; Año: 2012 p. 25325 - 25334
GRASSO, D; ROPOLO, A; LO RE, A; BOGGIO, V; MOLEJON, MI; IOVANNA, JL; GONZALEZ, D; URRUTIA, R; VACCARO, MI
Zymophagy, a novel selective autophagy pathway mediated by VMP1-USP9x-p62, prevents pancreatic cell death
JOURNAL OF BIOLOGICAL CHEMISTRY; Año: 2011 vol. 286 p. 8308 - 8324
ROPOLO A; BAGNES C.I.; MOLEJON MI; LO RE A; BOGGIO V; GONZALEZ CD; VACCARO MI
Chemotherapy and Autophagy-Mediated Cell Death in Pancreatic Cancer Cells
PANCREATOLOGY; Lugar: Basel; Año: 2011